This study will consist of a parallel-groups design, with 30 healthy active female participants randomly assigned to either an experimental heat acclimation and exercise intervention, or a thermo-neutral exercise intervention control group. Interventions will be 10 days in duration, and consist of daily 60-minute exercise bouts under the appropriate environmental condition. Before and after each intervention, various tests will be conducted to establish exercise capacity under various environmental conditions, as well as underlying mechanisms of physiological adaptation induced by each intervention.
Most research on how the human body responds to different environmental conditions has primarily focused on men, leaving a gap in our understanding of how women adapt to these conditions. Heat exposure in particular is known to affect the well-being and performance of humans, as well as induce chronic adaptations through an acclimation/acclimatization process, which helps the body to better regulate core temperature. Moreover, contemporary research is beginning to explore the 'cross-tolerance' phenomenon; the notion that exposure (and acclimation/acclimatization) to one environmental stressor may affect the responses to another. In particular, both heat and hypoxia are known to activate common acclimatization pathways, with pulmonary, cardiovascular, hematological and muscular adaptations occurring to facilitate both oxygen transport and core body temperature regulation. In line with this background, the primary aim of this study is to investigate the effects of a heat acclimation and exercise intervention, relative to a thermo-neutral exercise control intervention, on exercise tolerance under various environmental conditions (heat, hypoxia, neutral) in healthy, active women. The secondary aim is to establish mechanisms of adaptation, by exploring the intervention-induced changes in pulmonary, cardiovascular, hematological and muscular factors, through various tests conducted at rest and during exercise. To address these aims, 30 healthy active female participants, aged between 18 and 35 years, will be randomized to either an experimental (heat acclimation and exercise training) or control (thermo-neutral exercise training) group. The experimental group will complete a 10-day heat acclimation training intervention, exercising for 60 minutes per day in a climactic chamber set to 35°C and 50% relative humidity. The control group will complete a similar exercise intervention, but under thermo-neutral conditions (23°C and 50% relative humidity). Before and after the intervention period, both groups will complete a wide variety of tests, including exercise capacity measurements under each environmental condition (heat \[35°C\], hypoxia \[Fraction of inspired oxygen = 0.135\], neutral \[23°C, FiO2 = 0.209\]), body composition assessments, lung function testing, hemoglobin mass and blood volume quantification, skeletal muscle mitochondrial function and vascular responsiveness assessment, and venous blood sampling for a variety of sex hormone-, redox balance-, hematopoietic-, heat shock protein-, hypoxia-inducible factor- and genetic-related markers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
30
10-day intervention consisting of daily 60-min exercise sessions aimed to induce increases in core body temperature, conducted in a climactic chamber set to 35°C and 50% relative humidity.
10-day intervention consisting of daily 60-min exercise sessions conducted in a climactic chamber set to 23°C and 50% relative humidity.
Jozef Stefan Institute
Ljubljana, SI, Slovenia
University of Ljubljana
Ljubljana, Slovenia
Exercise capacity under thermo-neutral normoxic conditions
Results of an incremental exercise test to exhaustion conducted at 23°C and an FiO2 of 0.209, quantified using maximal oxygen uptake
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Exercise capacity under hot normoxic conditions
Results of an incremental exercise test to exhaustion conducted at 35°C and an FiO2 of 0.209, quantified using maximal oxygen uptake
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Exercise capacity under thermo-neutral hypoxic conditions
Results of an incremental exercise test to exhaustion conducted at 23°C and an FiO2 of 0.135, quantified using maximal oxygen uptake
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Core body temperature regulation during exercise
Core body temperature measured throughout the incremental exercise tests using a rectal temperature probe.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Skin temperature regulation during exercise
Skin temperature measured throughout the incremental exercise tests using temperature probes attached to the calf, thigh, chest and arm, from which weighted averages are calculated.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Sweat rates during exercise
Sweat rate measured throughout the incremental exercise tests using a sensor attached to the forehead.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Hemo-dynamic activity during exercise
Cardiac output measured throughout the incremental exercise tests by bio-electrical impedance cardiography.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Pulmonary ventilation during exercise
Pulmonary ventilation measured throughout the incremental exercise tests using flow measurements as recorded by metabolic cart.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Gas exchange during exercise
Balance of oxygen uptake and carbon dioxide production measured throughout the incremental exercise tests using gas composition sensors recorded by metabolic cart.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Muscle oxygenation during exercise
Vastus lateralis oxygenation measured throughout the incremental exercise tests using near-infrared spectroscopy.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Brain oxygenation during exercise
Cerebral oxygenation measured at the left pre-frontal cortex throughout the incremental exercise tests using near-infrared spectroscopy.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Pulse oxygen saturation during exercise
Capillary oxygen saturation measured on the right earlobe throughout the incremental exercise tests using pulse oximetry.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Body composition
Body mass measured using standard weighing scales, with body fat percentage estimated using a standardized eight-site skinfold measurement protocol with associated equation.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Lung function
Standard spirometry procedure to assess lung function using forced expiratory volume
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Hemoglobin mass
Hemoglobin mass estimation using the carbon monoxide re-breathing method
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Blood/plasma volume
Blood/plasma volume estimation using the carbon monoxide re-breathing method
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Skeletal muscle mitochondrial function
Skeletal muscle mitochondrial function quantified using a peripheral vascular occlusion test, with the rate of decrease in muscle oxygenation used to estimate mitochondrial function.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Skeletal muscle vascular responsiveness
Skeletal muscle vascular responsiveness quantified using a peripheral vascular occlusion test, with the rate of increase in muscle oxygenation during re-perfusion, and the oxygenation overshoot relative to pre-occlusion baseline, used to estimate vascular responsiveness.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Blood viscosity
Blood viscosity will be measured by obtaining venous blood samples from the participants, extracting plasma, and using a cone/plate viscometer to quantify viscosity and varying shear rates.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Oxidative stress marker
Venous blood samples will be obtained to quantify redox balance from the extracted plasma.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Hematopoiesis
Venous blood samples will be obtained to measure various markers of hematopoiesis from the extracted plasma, serum and/or whole blood.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Heat shock proteins
Venous blood samples will be obtained to measure heat shock proteins in the extracted plasma and serum.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
Hypoxia-inducible factor 1α
Venous blood samples will be obtained to measure hypoxia-inducible factor 1α in the extracted plasma and serum.
Time frame: Measured once before (pre) and once up to 1 week after (post) the intervention period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.